teriflunomide

Details

Files

Generic Name:

teriflunomide

Project Status:

Pending

Therapeutic Area:

Multiple Sclerosis (MS)

Manufacturer:

N/A

Call for patient/clinician input open:

July 2, 2024

Brand Name:

N/A

Project Line:

Reimbursement Review

Project Number:

SX0752-000

Call for patient/clinician input closed:

August 21, 2024

Biosimilar:

No

Submission Type:

Non-sponsored Submission

Fee Schedule:

Pending

Indications:

Radiologically Isolated Syndrome (RIS)

Files

Proposed Scope View PDF

Last Updated : July 2, 2024